Thomas O Cameron
Overview
Explore the profile of Thomas O Cameron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wemlinger S, Parker Harp C, Yu B, Hardy I, Seefeldt M, Matsuda J, et al.
J Immunol
. 2022 Mar;
208(7):1566-1584.
PMID: 35321883
The BCR comprises a membrane-bound Ig that is noncovalently associated with a heterodimer of CD79A and CD79B. While the BCR Ig component functions to sense extracellular Ag, CD79 subunits contain...
2.
Pellerin K, Rubino S, Burns J, Smith B, Mccarl C, Zhu J, et al.
Brain
. 2021 Jun;
144(8):2361-2374.
PMID: 34145876
Autoantibodies are a hallmark of numerous neurological disorders, including multiple sclerosis, autoimmune encephalitides and neuromyelitis optica. Whilst well understood in peripheral myeloid cells, the pathophysiological significance of autoantibody-induced Fc receptor...
3.
Arndt J, Qian F, Smith B, Quan C, Kilambi K, Bush M, et al.
Sci Rep
. 2018 Apr;
8(1):6412.
PMID: 29686315
Aducanumab, a human-derived antibody targeting amyloid-β (Aβ), is in Phase 3 clinical trials for the treatment of Alzheimer's disease. Biochemical and structural analyses show that aducanumab binds a linear epitope...
4.
Vollmann E, Cao L, Amatucci A, Reynolds T, Hamann S, Dalkilic-Liddle I, et al.
Mol Ther Nucleic Acids
. 2017 Jun;
7:314-323.
PMID: 28624207
Fibrotic diseases contribute to 45% of deaths in the industrialized world, and therefore a better understanding of the pathophysiological mechanisms underlying tissue fibrosis is sorely needed. We aimed to identify...
5.
Pellerin A, Otero K, Czerkowicz J, Kerns H, Shapiro R, Ranger A, et al.
EMBO Mol Med
. 2015 Mar;
7(4):464-76.
PMID: 25762615
Type I interferons (IFN-I) are implicated in the pathogenesis of systemic lupus erythematosus (SLE). In SLE, immune complexes bind to the CD32a (FcγRIIa) receptor on the surface of plasmacytoid dendritic...
6.
Waite J, Vardhana S, Shaw P, Jang J, Mccarl C, Cameron T, et al.
Eur J Immunol
. 2013 Aug;
43(12):3343-54.
PMID: 23939929
Entry of lymphocytes into secondary lymphoid organs (SLOs) involves intravascular arrest and intracellular calcium ion ([Ca(2+)]i) elevation. TCR activation triggers increased [Ca(2+)]i and can arrest T-cell motility in vitro. However,...
7.
Beal A, Anikeeva N, Varma R, Cameron T, Vasiliver-Shamis G, Norris P, et al.
Immunity
. 2009 Oct;
31(4):632-42.
PMID: 19833088
Cytolytic granules mediate killing of virus-infected cells by cytotoxic T lymphocytes. We show here that the granules can take long or short paths to the secretory domain. Both paths utilized...
8.
Kim N, Stiegler A, Cameron T, Hallock P, Gomez A, Huang J, et al.
Cell
. 2008 Oct;
135(2):334-42.
PMID: 18848351
Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane...
9.
Beal A, Anikeeva N, Varma R, Cameron T, Norris P, Dustin M, et al.
J Immunol
. 2008 Sep;
181(7):4815-24.
PMID: 18802085
Destruction of virus-infected cells by CTL is an extremely sensitive and efficient process. Our previous data suggest that LFA-1-ICAM-1 interactions in the peripheral supramolecular activation cluster (pSMAC) of the immunological...
10.
Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, Cameron T, et al.
J Immunol
. 2008 Aug;
181(5):3099-107.
PMID: 18713980
Recruitment of effector T cells to inflamed peripheral tissues is regulated by chemokines and their receptors, but the factors regulating recruitment to tumors remain largely undefined. Ionizing radiation (IR) therapy...